Mobilization of stem and progenitor cells in cardiovascular diseases

W Wojakowski1, U Landmesser, R Bachowski

  • 1Third Division of Cardiology, Medical University of Silesia, Katowice, Poland. wojtek.wojakowski@gmail.com

Leukemia
|July 27, 2011
PubMed

Insights

Mobilized stem and progenitor cells (SPCs) from bone marrow aid vascular and heart repair after injury. Their function is impaired by cardiovascular risk factors but may predict outcomes in certain patients.

Area of Science:

  • Cardiovascular Research
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Bone marrow-derived stem and progenitor cells (SPCs) are crucial for repairing vascular endothelium and heart muscle after acute coronary syndromes.
  • Acute myocardial infarction triggers inflammation, mobilizing SPCs and increasing local chemoattractants, while neural and humoral signals promote their release from bone marrow.
  • Various circulating SPC types exist, but their exact roles in myocardial and endothelial repair remain unclear.

Purpose of the Study:

  • To review the mobilization of SPCs in acute ischemia and stable cardiovascular disease.
  • To highlight the potential of SPCs as cardiovascular risk markers.
  • To discuss factors influencing SPC mobilization and function.

Main Methods:

  • Literature review of studies on stem and progenitor cell mobilization.
  • Analysis of the role of SPCs in myocardial infarction and stroke.
  • Examination of factors affecting SPC number and function, including cardiovascular risk factors, exercise, and statins.

Main Results:

  • The number and function of circulating SPCs are reduced in patients with diabetes and other cardiovascular risk factors.
  • Physical exercise and statin use can improve SPC function.
  • Mobilization of SPCs in acute coronary syndromes and stable coronary artery disease may predict clinical outcomes.

Conclusions:

  • SPCs play a role in cardiovascular repair, but their contribution requires further elucidation.
  • Factors like coexisting diseases, age, and medications influence SPC mobilization and must be considered.
  • Circulating SPCs hold potential as biomarkers for cardiovascular risk assessment.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...